Custom service
Targeting Peptide Design and Screening
Design and screen targeting peptides against a defined receptor
Targeting Peptide Design and Screening supports programmes that design and screen targeting peptides against a defined receptor. In a typical engagement we plan the structure- and motif-informed design route first, confirm compatibility with phage/biopanning screening routes, and release validated targeting motif with affinity and specificity data on a 6–10 weeks schedule.
Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep structure- and motif-informed design as the primary option and hold phage/biopanning screening routes in reserve, so that scale-up never depends on an unproven step.
New targets without a published binding motif
Improving affinity or specificity of an existing motif
Programs with no access to target receptor reagents
Targets whose soluble ectodomain cannot be produced or sourced for binding assays
Binding affinity and specificity data are generated in-house for every campaign: IC50 or Kd against the intended target, plus counterscreens against the closest homologs. Release also includes purity, identity and, for conjugated variants, loading ratio.
Service Highlights
- Structure- and motif-informed design as the default route, with phage/biopanning screening routes held as a proven fallback
- SPR and cell-binding confirmation worked into the design where the application requires it
- Receptor-binding assays run against the intended target before any scale-up
- Analytical confirmation of every intermediate before the final release
- Specificity is measured against a negative-cell or negative-receptor panel, not asserted
- Validated targeting motif with affinity and specificity data delivered with a complete conjugation or synthesis certificate
How the work runs
Target analysis
We map the binding site, receptor biology and homolog panel that the Targeting Peptide Design and Screening campaign must respect.
Motif selection or discovery
A motif is selected from literature, or discovered by screening, and candidate sequences are ranked.
Synthesis & modification
Candidates are synthesized with structure- and motif-informed design applied to stabilize or direct the motif.
Binding & specificity testing
Affinity is measured on the target and counterscreens run on homologs and irrelevant cells.
Optimization round
Sequences are iterated — alanine scanning, truncation, D-substitution — until the specification is met.
Scale-up & release
The final variant is produced in quantity and Validated targeting motif with affinity and specificity data is released with the full data package.
Specifications & timeline
- Turnaround
- 6–10 weeks
- Typical scale
- 1 – 100 mg targeting peptide
- Chemistry options
- structure- and motif-informed design; phage/biopanning screening routes; SPR and cell-binding confirmation
- Deliverable
- Validated targeting motif with affinity and specificity data
- QC package
- HPLC purity, MS identity, binding assay report
- Shipping
- Ambient or blue ice as stability requires
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.